Remifemin
This article was originally published in The Tan Sheet
Executive Summary
GSK did not provide International Menopause Society with unrestricted educational grant to create Powering Informed Choices Initiative, which promotes firm's Remifemin, as stated in 1"The Tan Sheet" Oct. 29, p. 13...
You may also be interested in...
Menopause Herbals Viewed Warily By Patients & Doctors, Surveys Show
Soy, vitamin E and black cohosh are the dietary supplement ingredients that doctors feel most comfortable recommending to their patients for menopause, according to a recent Southern California University of Health Sciences survey.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.